FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: To generate dystroglycanopathy iPSCs, we reprogrammed the patient's fibroblasts carrying the FKRP c.1364C>A mutations using a six‐factor reprogramming technology based on a doxycycline‐inducible system 49.